Stuart Hollenshead - 17 Feb 2025 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Reporting relationship: Chief Operating Officer
Issuer ticker: PRPH
Reported as of: 17 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Feb 2025, 17:15:08 UTC
Prior SEC filing: 21 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Stuart Hollenshead

Key filing fact

Stuart Hollenshead filed Form 4 for ProPhase Labs, Inc. (PRPH) on 21 Feb 2025.

Key facts

This page summarizes Stuart Hollenshead's Form 4 filing for ProPhase Labs, Inc. (PRPH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Feb 2025, 17:15.

Change

Previous filing in this sequence was filed on 21 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRPH transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 17 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.6000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock option granted as an inducement award. The option vests over a three-year period, with 25% vesting on the date of grant and 25% vesting on each of the next three anniversaries thereafter, subject to the Reporting Person's continued service through each vesting date.